The EV-transmitted p120ctn has also been found to thwart HCC progression by inhibiting the STAT3 pathway, suggesting that p120ctn-containing EVs derived from cancer cells may be used as a therapeutic agent to treat liver cancer [37]. Here, CTNND1 is linked to liver cancer.